C

    CareDx Inc (CDNA)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $50.11
    +0.32 (+0.64%)

    Market Cap: $2.58B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    78%(31/40)
    Avg Surprise
    +134.88%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.25
    Range$0.23 - $0.27
    6 analysts
    EPS Revisions
    5
    0
    7d
    5
    0
    30d
    EPS Estimate Drift
    90d ago$0.19-24.8%
    60d ago$0.19-24.8%
    30d ago$0.19-24.8%
    7d ago$0.19-24.8%
    Current$0.25
    Revenue Consensus
    $122M
    Range$121M - $124M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.60
    Range$0.58 - $0.63
    6 analysts
    Revenue Consensus
    $155M
    Range$154M - $155M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.60---
    Sep 26EST
    		-$0.25---
    Jun 26
    Reported Jul 30
    		$0.17$0.06+183.33%Beat+70.0%
    Mar 26
    Reported Apr 28
    		$0.34$0.13+161.54%Beat+240.0%
    Dec 25
    Reported Feb 24
    		$0.12$-0.01+1300.00%Beat-33.3%
    Sep 25
    Reported Nov 4
    		$0.28$0.14+100.00%Beat+100.0%
    Jun 25
    Reported Aug 6
    		$0.10$0.12-16.67%Miss-60.0%
    Mar 25
    Reported Apr 30
    		$0.10$0.07+42.86%Beat+433.3%
    Dec 24
    Reported Feb 26
    		$0.18$0.15+22.03%Beat+205.9%
    Sep 24
    Reported Nov 4
    		$0.14$0.01+1300.00%Beat+177.8%
    Jun 24
    Reported Jul 31
    		$0.25$-0.14+278.57%Beat+238.9%
    Mar 24
    Reported May 9
    		$-0.03N/A+85.71%Beat+72.7%
    Dec 23
    Reported Feb 28
    		$-0.17$-0.27+37.04%Beat-142.9%
    Sep 23
    Reported Nov 8
    		$-0.18N/A+55.00%Beat-200.0%
    Jun 23
    Reported Aug 8
    		$-0.18$-0.31+41.94%Beat-38.5%
    Mar 23
    Reported May 10
    		$-0.11$-0.10-10.00%Miss+15.4%
    Dec 22
    Reported Feb 27
    		$-0.07$-0.09+22.22%Beat-133.3%
    Sep 22
    Reported Nov 3
    		$-0.06N/A+57.14%Beat-185.7%
    Jun 22
    Reported Aug 4
    		$-0.13$-0.11-18.18%Miss-218.2%
    Mar 22
    Reported May 5
    		$-0.13$-0.04-225.00%Miss-192.9%
    Dec 21
    Reported Feb 24
    		$-0.03$0.03-200.00%Miss-137.5%
    Sep 21
    Reported Oct 28
    		$0.07$0.02+250.00%Beat-30.0%
    Jun 21
    Reported Jul 29
    		$0.11$0.06+83.33%Beat+175.0%
    Mar 21
    Reported May 5
    		$0.14$0.01+1300.00%Beat+200.0%
    Dec 20
    Reported Feb 24
    		$0.08$0.02+300.00%Beat+100.0%
    Sep 20
    Reported Oct 29
    		$0.10$-0.06+266.67%Beat+400.0%
    Jun 20
    Reported Aug 4
    		$0.04$-0.04+200.00%Beat+121.1%
    Mar 20
    Reported Apr 30
    		$-0.14$0.03-566.67%Miss-380.0%
    Dec 19
    Reported Feb 27
    		$0.04$0.02+100.00%Beat+300.0%
    Sep 19
    Reported Oct 31
    		$0.02$0.01+100.00%Beat+300.0%
    Jun 19
    Reported Aug 1
    		$-0.19$-0.10-90.00%Miss-375.0%
    Mar 19
    Reported May 8
    		$0.05$-0.04+225.00%Beat+135.7%
    Dec 18
    Reported Mar 6
    		$0.01N/A+111.11%Beat+111.1%
    Sep 18
    Reported Nov 8
    		$-0.01N/A+66.67%Beat+93.3%
    Jun 18
    Reported Aug 9
    		$-0.04$-0.07+42.86%Beat+76.5%
    Mar 18
    Reported May 10
    		$-0.14$-0.13-7.69%Miss-7.7%
    Dec 17
    Reported Mar 22
    		$-0.09$-0.13+30.77%Beat+87.7%
    Sep 17
    Reported Nov 9
    		$-0.15$-0.17+11.76%Beat+0.0%
    Jun 17
    Reported Aug 10
    		$-0.17$-0.20+15.00%Beat-
    Mar 17
    Reported Apr 21
    		$-0.13$-0.17+23.53%Beat-
    Dec 16
    Reported Mar 23
    		$-0.73$-0.18-305.56%Miss-
    Sep 16
    Reported Nov 9
    		$-0.15$-0.19+21.05%Beat-

    Key Metrics

    Valuation
    P/E Ratio55.07EV/EBITDA151.33x
    Price/FCF30.45xFCF Yield3.28%
    Profitability
    Profit Margin24.20%Operating Margin0.20%
    ROE29.50%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio4.58xQuick Ratio4.51x
    Trading Statistics
    Beta2.42Avg Volume1.20M
    52-Week High$53.6752-Week Low$12.37

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$48.98
    SMA 20$47.73
    SMA 50$38.83
    SMA 200$24.39
    EMA 10$49.22
    EMA 20$46.97
    EMA 50$40.29
    EMA 200$27.44

    MACD

    Line: 3.30Signal: 3.51Hist: -0.21

    ADX

    ADX: 51.8+DI: 32.4-DI: 19.3

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down12.0
    PSAR$45.73

    Bollinger Bands

    Upper Band$51.84
    Lower Band$43.62
    %B Position1720%(Upper)
    Band Width0.79

    RSI (14-Day)

    Neutral
    65.3

    Momentum Oscillators

    Stoch %K67.1
    Stoch %D79.8
    Williams %R-40.1
    ROC (10d)8.0%
    Momentum3.73
    CCI (20d)66.8
    MFI (14d)57.0

    Volatility Measures

    ATR (14d)$2.42(4.8%)
    StdDev (20d)2.05
    Hist Vol45.6%(High)

    Volume Flow

    VWAP$49.03
    OBV39.5M
    AD Line12.7M
    CMF (20d)0.123

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio1.4x
    VWMA (20d)$48.05

    Pivot Points

    R3$54.36
    R2$53.37
    R1$51.58
    Pivot Point$50.59
    S1$48.80
    S2$47.81
    S3$46.02

    Advanced Oscillators

    TSI39.11
    Ultimate Osc66.5
    KST346.53

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$263.90M$117.70M$108.39M$100.06M$86.68M$84.69M$86.58M$82.88M$92.27M$72.05M$65.57M$67.19M
    Cost of Revenue$34.97M$33.63M$35.51M$30.65M$28.66M$28.41M$28.19M$27.57M$28.00M$25.93M$25.68M$24.53M
    Gross Profit$228.93M$84.07M$72.87M$69.40M$58.02M$56.27M$58.39M$55.31M$64.28M$46.12M$39.89M$42.66M
    Operating Expenses$115.45M$82.87M$78.91M$69.65M$69.14M$69.64M$-25,991,000$69.03M$71.60M$68.68M$162.52M$71.44M
    R&D$22.38M$21.42M$19.31M$16.77M$16.83M$18.52M$16.62M$17.49M$19.69M$18.71M$18.83M$19.00M
    SG&A$40.91M$30.48M$28.68M$28.43M$27.68M$22.77M$32.35M$31.74M$30.91M$30.14M$27.51M$33.97M
    Operating Income$113.22M$1.20M$-6,040,000$-246,000$-11,121,000$-13,374,000$84.38M$-13,721,000$-7,327,000$-22,566,000$-122,632,000$-28,783,000
    Interest Income$1.74M$1.91M$2.01M$2.01M$2.36M$2.78M$3.05M$3.00M$2.83M$2.88M$3.16M$3.17M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$114.52M$2.78M$-3,763,000$1.66M$-8,685,000$-10,295,000$87.87M$-10,437,000$-4,601,000$-19,971,000$-117,932,000$-23,565,000
    Income Tax Expense$3.88M$-32,012$345,000$-15,000$-117,000$58,000$171,000$200,000$22,000$-83,000$165,000$-80,000
    Net Income$110.64M$2.81M$-4,108,000$1.68M$-8,568,000$-10,353,000$87.70M$-10,637,000$-4,623,000$-19,888,000$-118,097,000$-23,485,000
    EBITDA$118.63M$7.10M$-736,000$5.74M$-6,271,000$-7,302,000$88.95M$-8,193,000$-3,100,000$-16,182,000$-117,559,000$-23,025,000
    EBIT$114.08M$868,000$-5,776,000$-353,000$-11,049,000$-13,079,000$84.81M$-13,438,000$-7,427,000$-22,856,000$-121,091,000$-26,736,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CDNA

    Government Contracts

    Gov Obligations (TTM)
    $4.45M
    Gov Obligations / Revenue
    1.0%
    Obligations YoY
    24.2%
    Active Awards
    11
    New Awards (TTM)
    5
    Avg Remaining Term
    7.9 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C25226N0079Department of Veterans AffairsDepartment of Veterans Affairs$1.60MFeb 1, 2026
    36C24926N0622Department of Veterans AffairsDepartment of Veterans Affairs$1.05MSep 23, 2026
    36C25225N0531Department of Veterans AffairsDepartment of Veterans Affairs$849384Sep 30, 2025
    36C25626N0370Department of Veterans AffairsDepartment of Veterans Affairs$770805Apr 1, 2026
    36C26326N0261Department of Veterans AffairsDepartment of Veterans Affairs$142038Jan 15, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Caredx Inc stock hits 52-week high at 49.77 USD By Investing.com

    Caredx Inc (CDNA) stock has reached a new 52-week high of $49.77, reflecting a robust 283.22% increase over the past year. Despite its current trading price of $49.69, InvestingPro's Fair Value analysis suggests the company might be overvalued, although it boasts a perfect Piotroski Score of 9 and an attractive PEG ratio of 0.2. This surge follows strong Q2 2026 results, where CareDx surpassed analyst expectations for both earnings and revenue, with total revenue rising 52% year-over-year to $131.9 million.

    Investing.com UK•8/25/26•
    Bullish

    Caredx Inc stock hits 52-week high at 49.77 USD

    Caredx Inc (CDNA) stock has hit a 52-week high of $49.77, trading at $49.69 with a market capitalization of $2.57 billion. This surge reflects a 283.22% increase over the past year, supported by a perfect Piotroski Score of 9 and an attractive PEG ratio of 0.2. The company recently reported strong Q2 2026 results, exceeding analyst expectations for both earnings and revenue, and raised its full-year outlook.

    Investing.com•8/25/26•
    Bullish

    CareDx (NASDAQ:CDNA) Combines Strong Growth With a Bullish Technical Setup

    CareDx (NASDAQ:CDNA) demonstrates strong revenue and earnings growth, coupled with a healthy balance sheet, making it an attractive prospect for growth investors. The company's technical setup indicates an emerging uptrend, with positive short-term and long-term trends and significant outperformance in the market. While the stock's P/E ratio is high and it has a history of negative earnings, its robust fundamentals and technical breakout align with a strategy for sustained growth.

    ChartMill•8/25/26•
    Bullish

    ETFs Investing in CareDx, Inc. Stocks

    This article lists various Exchange Traded Funds (ETFs) that hold stocks of CareDx, Inc. The ETFs are sorted by their market value of CareDx, Inc. stocks and include details such as weight, issuer, management style, focus, expense ratio, AUM, price, change, relative volume, and 3-year NAV total return. The list provides potential investment opportunities in CareDx, Inc. through diversified funds.

    TradingView•8/24/26•
    Neutral

    CareDx Inc (1K9) Q1 2026 Earnings Report - Results, Call & Slides

    CareDx Inc. (1K9) has released its Q1 2026 earnings report, showing a significant beat on both EPS and revenue expectations. The company reported actual EPS of €0.30 against a consensus of €0.12, and actual revenue of €102.13M compared to an expected €88.53M, marking a nearly 39% year-over-year revenue growth. The earnings call took place on April 28, 2026, and the next earnings date is estimated for November 10, 2026.

    TipRanks•8/22/26•
    Neutral

    Frequently Asked Questions About CDNA

    Does CDNA pay dividends?
    CareDx Inc (CDNA) does not currently pay a regular dividend.
    What is CDNA's P/E ratio?
    CareDx Inc has a price-to-earnings (P/E) ratio of 55.07.
    What is CDNA's market cap?
    CareDx Inc (CDNA) has a market capitalization of $2.58B with a current stock price of $50.11.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In